You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 167 No. 2, January 22, 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Error in Abstract and Text in: A Double-blind, Placebo-Controlled, Crossover Study of Sildenafil in Obstructive Sleep Apnea

Arch Intern Med. 2007;167(2):207.

Errors in Abstract and Text. In the Original Investigation by Roizenblatt et al titled "A Double-blind, Placebo-Controlled, Crossover Study of Sildenafil in Obstructive Sleep Apnea," published in the September 18 issue of the ARCHIVES (2006;166:1763-1767), errors appeared in both the abstract and the text. In the "Methods" section of the abstract, the first word should have been "Thirteen" because 13, rather than 14, participants were included in the study; therefore, the "Results" section of the abstract should have read, "In comparison to placebo, a single 50-mg dose of sildenafil significantly increased the percentage of total sleep time with an arterial oxygen saturation of less than 90% (mean ± SD, 15.6% ± 9.6% vs 7.9% ± 3.3%, P<.01), without a difference in the nadir of oxygen desaturation. The mean arterial oxygen saturation also decreased (92.1%±1.9% vs 93.8% ± 1.3%, P=.03), and the desaturation index increased (30.3 ± 14.5 events per hour vs 18.5 ± 9.1 events per hour, P<.001). There was an increase in apnea-hypopnea index (48.1 ± 20.8 events per hour vs 32.3 ± 11.3 events per hour, P<.001), involving mostly obstructive events." Also, the first sentence of the "Results" section of the text on page 1764 should have read, "As mentioned, after screening for cardiovascular and pulmonary disease or metabolic syndrome, only 13 of the 49 middle-aged men with severe OSA recruited for this study were selected (age, 53.1±9.8 years; body mass index, 26.7 ± 1.9)."







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.